Table 4

T-ALL engraftment in NSG mice

Bulk T-ALL cell dosePatient samplesNo. of engrafted/total no. of injected
1 × 107 5747, 4289 5/5 
7 × 106 7017, 80150 7/8 
1 × 106 80150, 5747, 4289, 90205 12/14 
8.3 × 105 5747 2/2 
7 × 105 7017, 80150 7/9 
1 × 105 80150, 5747, 90205 11/14 
7 × 104 7017, 80150 4/10 
1 × 104 80150, 5747, 90205 8/13 
7 × 103 7017, 80150 2/10 
1 × 103 80150, 90205 2/5 
Bulk T-ALL cell dosePatient samplesNo. of engrafted/total no. of injected
1 × 107 5747, 4289 5/5 
7 × 106 7017, 80150 7/8 
1 × 106 80150, 5747, 4289, 90205 12/14 
8.3 × 105 5747 2/2 
7 × 105 7017, 80150 7/9 
1 × 105 80150, 5747, 90205 11/14 
7 × 104 7017, 80150 4/10 
1 × 104 80150, 5747, 90205 8/13 
7 × 103 7017, 80150 2/10 
1 × 103 80150, 90205 2/5 

Engraftment was considered as positive if there was > 2% human CD45+CD7+CD5+ cells in the RF as detected by flow cytometry. Limiting dilution analysis using L-Calc software found that L-IC frequency is 1 in 6.3 × 105 cells (95% confidence interval from 1 in 4.0 × 105 to 1 in 1.0 × 107).

Close Modal

or Create an Account

Close Modal
Close Modal